The effect of Angiojet rheolytic thrombectomy in the endovascular treatment of lower extremity deep venous thrombosis

Abstract

Objective

To evaluate the clinical safety and effectiveness of percutaneous rheolytic thrombectomy in patients with acute lower extremity deep venous thrombosis.

Method

Sixty-eight consecutive patients with acute massive lower extremity deep venous thrombosis were included in this retrospective study. A percutaneous rheolytic thrombectomy device (Angiojet ® Rheolytic thrombectomy catheter, Boston Scientific, Marlborough, MA, USA) was used in all patients in an angiography suite through ipsilateral popliteal vein access. Thrombus clearance and complications were evaluated. Furthermore, patients underwent a clinical evaluation according to a modified Villalta scale for the investigation of post thrombotic syndrome in follow-up. The Venous Clinical Severity Score, Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Sym questionnaires were completed preoperatively and readministered postoperatively.

Results

Overall thrombus clearance (complete recanalization was achieved in 58 patients (85.2%) and partial recanalization was achieved in 7 patients (10.2%) confirmed through venographic assessment was achieved in 95.5% of the patient population. The mean Venous Clinical Severity Score preoperatively was 13.1 ± 2.2 and decreased to 4.0 ± 1.3 postoperatively (P < 0.01). The Villalta scale dropped from 12.9 ± 2.8 to 5.5 ± 1.4 postoperatively (P < 0.001). Overall quality of life and symptoms improved as assessed by Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Sym (P < 0.01 and 0.02, respectively). Only three minor bleedings were seen but none of the patients suffered from major bleeding, symptomatic pulmonary embolism, death, or other procedure related complications. Fifty-nine out of 65 patients (90.7%) who were treated successfully with rheolytic thrombectomy remained patent at 12 months according to DUS and five patients (7.3%) developed a mild post thrombotic syndrome.

Conclusion

Rheolytic thrombectomy with or without stenting is superior to anticoagulant therapy alone in terms of both ensuring venous patency and improving clinical symptoms. This technique is a safe, effective and easily performed method of endovascular treatment with a low rate of major treatment complications and shows promising clinical mid-term results.

Keywords

Catheter-based interventions endovascular treatment deep vein thrombosis mechanical thrombectomy post-thrombotic syndrome

Get full access to this article

View all access options for this article.

References

Rabinovich

Kahn

. The postthrombotic syndrome: current evidence and future challenges. J Thromb Haemost 2017; 15: 230–241.

Farrell

Sutter

Tavri

et al.

Incidence and interventions for post-thrombotic syndrome. Cardiovasc Diagn Ther 2016; 6: 623–631.

Behravesh

Hoang

Nanda

et al.

Pathogenesis of thromboembolism and endovascular management. Thrombosis 2017; 2017: 3039713–3039713.

Dumantepe

Tarhan

Yurdakul

et al.

US-accelerated catheter-directed thrombolysis for the treatment of deep venous thrombosis. Diagn Interv Radiol 2013; 19: 251–258.

Meissner

Gloviczki

Comerota

et al.

Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012; 55: 1449–1462.

Utne

Tavoly

Wik

et al.

Health-related quality of life after deep vein thrombosis. Springerplus 2016; 5: 1278–1278.

Comerota

. Deep venous thrombosis and postthrombotic syndrome: invasive management. Phlebology 2015; 30(1 Suppl): 59–66.

Kearon

Kahn

Agnelli

et al.

Antithrombotic therapy for venous thromboembolic disease: ACCP evidence-based clinical practice guidelines (8th ed). Chest 2008; 133: 454–545.

Kahn

Partsch

Vedantham

et al.

Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 2009; 7: 879–883.

10.

Kahn

Lamping

Ducruet

et al.

Veines-QOL/Sym questionnaire was a reliable and valid disease specific quality of life measure for deep venous thrombosis. J Clin Epidemiol 2006; 59: 1049–1056.

11.

Karthikesalingam

Young

Hinchliffe

et al.

A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Eur J Vasc Endovasc Surg 2011; 41: 554–565.

12.

Elsharaway

Elzayat

. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2005; 24: 209–214.

13.

Enden

Haig

Klow

et al.

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2002; 379: 31–38.

14.

Hager

You

Avgerinos

et al.

Anatomic and functional outcomes of pharmacomechanical and catheter- directed thrombolysis of iliofemoral deep venous thrombosis. J Vasc Surg 2014; 2: 246–252.

15.

Lin

Zhou

Dardik

et al.

Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192: 782–788.

16.

Kim

Patra

Paxton

et al.

Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosis. Cardiovasc Intervent Radiol 2006; 29: 1003–1007.

17.

Garcia

Lookstein

Malhotra

et al.

Endovascular management of deep vein thrombosis with rheolytic thrombectomy: Final report of the prospective multicenter PEARL (peripheral use of AngioJet rheolytic thrombectomy with a variety of catheter lengths) registry. J Vasc Interv Radiol 2015; 26: 777–785.

18.

Nyamekye

Merker

. Management of proximal deep vein thrombosis. Phlebology 2012; 27 Suppl 2: 61–72.

19.

Rhodes

Cho

Gloviczki

et al.

Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg 2000; 31: 1193–1205.

20.

Laiho

Oinonenb

Suganob

et al.

Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. Eur J Vasc Endovasc Surg 2004; 28: 391–396.

21.

Agle

McNally

Powell

et al.

The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis. Ann Vasc Surg 2010; 24: 609–614.

22.

Kahn

Ducruet

Arsenault

et al.

Predictors of the post-thrombotic syndrome after acute deep venous thrombosis: two-year results from a Canadian multicenter prospective cohort study (The VETO Study). Blood 2005; 106: 1635–1635.